Published on 26/11/2025

Handling Algorithm Changes: Verification vs Re-Validation

In the evolving landscape of pharmaceutical manufacturing, visual inspection and automated inspection systems (AIS) play a critical role in ensuring product quality and patient safety. With the increasing reliance on advanced inspection algorithms, understanding the distinction between verification and re-validation in the context of algorithm changes becomes paramount. This guide outlines a structured approach to navigating algorithm modifications within AIS, focusing on how they meet regulatory expectations from authorities such as the FDA, EMA, and MHRA.

Understanding the Importance of Algorithm Changes in AIS

Visual inspection qualification is integral to the quality assurance framework in pharmaceuticals. Automated inspection systems utilize sophisticated algorithms to detect defects in products efficiently. Changes to these algorithms are not uncommon, driven by advancements in technology or the need for improved defect detection. Nonetheless, such changes can significantly impact system performance and product quality. Therefore, it is crucial to assess when verification is sufficient and when re-validation becomes necessary.

The governing regulations, such as 21 CFR Part 11 in the US, emphasize the importance of maintaining system integrity and data reliability. Compliance with these regulations ensures that any algorithmic changes do not detrimentally affect the inspection process or product quality. Similarly, regulations like Annex 1 and Annex 15 under the EU guidelines highlight the need for rigorous validation measures to maintain product safety and efficacy.

Defining the scope and impact of algorithm changes is crucial. Factors to consider include:

• The nature of the changes—were they fundamental to algorithm logic or minor adjustments?
• The potential impact on defect detection rates and overall performance.
• The previous qualification results and historical data trends.

Steps to Assess Algorithm Changes in AIS

Implementing a structured approach to assess the impact of algorithm changes is essential for maintaining compliance and ensuring product quality. Below is a step-by-step tutorial guide for evaluating these changes effectively.

Step 1: Document Algorithm Changes

The first step involves meticulous documentation of the algorithm changes. This should include:

• A detailed description of the changes made.
• The reason for the change, including any underlying data or studies supporting the decision.
• An analysis of how these changes align with the predefined user requirements as stated in the User Requirement Specification (URS).

This documentation becomes crucial for both internal assessments and external regulatory audits. Maintaining a clear record ensures traceability and provides a comprehensive overview of the inspection system’s evolution.

Step 2: Risk Assessment

Conducting a thorough risk assessment is critical to determine the possible consequences of the algorithm changes. Incorporate elements of Failure Mode Effects Analysis (FMEA) to identify and mitigate risks associated with the algorithm modification. Key aspects to evaluate include:

• Identifying potential points of failure in the new algorithm.
• Assessing the impact of these failures on product quality and patient safety.
• Developing mitigation strategies to address identified risks.

This proactive approach helps maintain compliance with regulatory expectations and enhances the reliability of inspection outcomes.

Step 3: Determine Verification vs Re-Validation

Deciding whether to perform verification or full re-validation hinges on the risk assessment’s findings and the extent of the algorithm change. Verification is typically sufficient for minor changes that do not materially alter the inspection process or performance. In contrast, major changes that redefine how defects are identified necessitate a comprehensive re-validation process.

Understand the following distinctions:

• Verification: Confirming that the changes have been implemented correctly and that the existing validation state remains applicable. This may include executing operational qualifications (OQ) and performance qualifications (PQ) under the new algorithm settings.
• Re-Validation: A complete review and re-assessment of the system as if it were new. This process encompasses the entire validation lifecycle, including IQ, OQ, and PQ, to ensure that the system meets pre-defined acceptance criteria and compliance regulatory guidelines.

Implementing Verification and Re-Validation Processes

Once the decision on verification versus re-validation is made, implementing the necessary processes is vital to ensure ongoing compliance and system effectiveness. Below are the key undertakings in each process.

Verification Process

The verification process requires the following key actions:

• Review Existing Qualification Documentation: Assess all pre-existing validation documents to ensure they remain applicable post-algorithm change.
• Conduct Targeted Testing: Execute targeted tests that specifically address the changes made to the algorithm, evaluating their impact on defect detection and performance.
• Compile Results: Document the results from verification testing, including any deviations and corrective actions taken.

This streamlined verification approach helps reaffirm the functionality and reliability of the inspection system while documenting compliance with applicable standards.

Re-Validation Process

In cases necessitating full re-validation, a comprehensive approach must encompass the entire validation lifecycle. Here are the steps included in the re-validation process:

• Installation Qualification (IQ): Confirm the system’s setup conforms with the manufacturers’ specifications, including hardware, software, and surrounding environment.
• Operational Qualification (OQ): Test operational parameters under normal operating conditions. Ensure various scenarios are executed to confirm the algorithm operates correctly under all expected conditions.
• Performance Qualification (PQ): Evaluate the overall performance of the algorithm in detecting and categorizing defects during a routine inspection cycle. Utilize challenge sets and a sound defect library to ensure robust testing.

Documenting the complete re-validation process is crucial for future audits and inspections. This documentation must align with the expectations set forth in regulatory guidance, providing assurance of product quality and safety.

Monitoring Performance Post-Validation

After completing the verification or re-validation process, the next phase is ongoing monitoring of the automated inspection system’s performance. Regular checks are invaluable for identifying anomalies or degradation in system performance over time. Key activities to implement include:

• Routine Checks: Regularly inspect the performance metrics of automated inspection systems, documenting any variations or trends.
• Trending Analysis: Utilize statistical analysis tools to assess the defect detection rates and false reject rates continuously. This analysis aids in determining if further action is needed to recalibrate or revise the inspection algorithms.
• Corrective and Preventive Actions (CAPA): Establish robust CAPA procedures to address any issues arising from the monitoring process. Ensure that complaints about false rejects or process deviations are documented and resolved promptly.

By instituting a comprehensive monitoring system, pharmaceutical companies can ensure continued compliance with regulatory requirements and maintain high product quality across their portfolio.

Conclusion

In the realm of pharmaceutical visual inspection and automated inspection systems, managing algorithm changes demands a comprehensive understanding of verification versus re-validation processes. By following a structured approach—documenting changes, conducting risk assessments, and implementing thorough verification and re-validation processes—pharmaceutical professionals can ensure compliance with regulatory expectations and uphold product safety and quality.

Ultimately, as novel technologies continue to redefine inspection methodologies, maintaining a proactive strategy in responding to algorithm modifications will be crucial to sustaining excellence in pharmaceutical manufacturing and visual inspection practices.